Lataa...
Biomarkers in DILI: One More Step Forward
Despite being relatively rare, drug-induced liver injury (DILI) is a serious condition, both for the individual patient due to the risk of acute liver failure, and for the drug development industry and regulatory agencies due to associations with drug development attritions, black box warnings, and...
Tallennettuna:
| Julkaisussa: | Front Pharmacol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4992729/ https://ncbi.nlm.nih.gov/pubmed/27597831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00267 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|